1
Consent
2
Information
3
Medical History
4
Review
Step 1: Informed Consent
This document provides essential information about the Alzheimer's research study. Please read it carefully.
Purpose of the Study: To evaluate the safety and efficacy of a new investigational drug for the treatment of mild to moderate Alzheimer's disease.
Procedures: Participants will undergo regular cognitive assessments, physical examinations, and brain imaging scans (MRI/PET). The study involves receiving either the investigational drug or a placebo via intravenous infusion every 4 weeks for a total of 72 weeks.
Risks and Discomforts: Potential risks include, but are not limited to, infusion-related reactions, headaches, dizziness, and amyloid-related imaging abnormalities (ARIA). All potential risks will be monitored closely by the study team.
Benefits: There may be no direct medical benefit to you for participating. However, your participation may contribute to a better understanding of Alzheimer's disease and help future patients.
Confidentiality: Your identity and medical information will be kept confidential as required by law. Research data will be anonymized.
Voluntary Participation: Your participation is voluntary. You may withdraw from the study at any time without penalty or loss of benefits to which you are otherwise entitled.
Step 2: Candidate & Study Partner Information
Please provide your information and the information of your study partner. You can upload an image of an ID (e.g., Driver's License) to automatically fill in the fields.
Onboarding Screen Mockups
Candidate Information
+ Upload ID Document
Use our OCR scanner
Scan Partner's ID
Scan Document
Candidate Information
Study Partner Information
Step 3: Medical History & Eligibility
Step 4: Review & Submit
Please review all the information carefully before submitting.
Application Submitted Successfully!
Thank you for your interest. A member of our research team will contact you within 5-7 business days to discuss the next steps.
